| Scientific Name |
Emicizumab
|
|---|---|
| Brand Name |
Hemlibra
|
| Risk |
Thromboembolism, thrombotic microangiopathy and laboratory coagulation test interference.
|
| Educational Materials for Healthcare Professionals |
|
| Educational Materials for Patients |
|